Literature DB >> 29846903

Primary hyperparathyroidism in prostate cancer: guilty or not guilty?

G Mazziotti1, S Frara2, A Mosca3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29846903     DOI： 10.1007/s12020-018-1632-2

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  36 in total

Review 1.  Drug-induced osteoporosis: mechanisms and clinical implications.

Authors:  Gherardo Mazziotti; Ernesto Canalis; Andrea Giustina
Journal:  Am J Med       Date:  2010-10       Impact factor: 4.965

2.  Prostate cancer treated with androgen deprivation therapy has consequences for bone.

Authors:  Robert A Adler
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

3.  Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study.

Authors:  Rebecca Pedersini; Sara Monteverdi; Gherardo Mazziotti; Vito Amoroso; Elisa Roca; Filippo Maffezzoni; Lucia Vassalli; Filippo Rodella; Anna Maria Formenti; Stefano Frara; Roberto Maroldi; Alfredo Berruti; Edda Simoncini; Andrea Giustina
Journal:  Bone       Date:  2017-01-16       Impact factor: 4.398

4.  Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration.

Authors:  Alfredo Berruti; Richard Cook; Fred Saad; Consuelo Buttigliero; Allan Lipton; Marco Tampellini; Ker-Ai Lee; Robert E Coleman; Matthew R Smith
Journal:  Oncologist       Date:  2012-04-20

5.  Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels.

Authors:  S Takahashi; M Hakuta; K Aiba; Y Ito; N Horikoshi; M Miura; K Hatake; E Ogata
Journal:  Endocr Relat Cancer       Date:  2003-09       Impact factor: 5.678

6.  Hyperparathyroidism and subsequent incidence of breast cancer.

Authors:  Karin B Michels; Fei Xue; Lena Brandt; Anders Ekbom
Journal:  Int J Cancer       Date:  2004-06-20       Impact factor: 7.396

7.  Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?

Authors:  Laure Michaud; Alice Burgess; Virginie Huchet; Marine Lefèvre; Marc Tassart; Jessica Ohnona; Khaldoun Kerrou; Sona Balogova; Jean-Noël Talbot; Sophie Périé
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

Review 8.  Cancer-associated bone disease.

Authors:  R Rizzoli; J-J Body; M-L Brandi; J Cannata-Andia; D Chappard; A El Maghraoui; C C Glüer; D Kendler; N Napoli; A Papaioannou; D D Pierroz; M Rahme; C H Van Poznak; T J de Villiers; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2013-10-22       Impact factor: 4.507

9.  Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer.

Authors:  Hai Huang; Chao Wang; Fei Liu; Hui-Zhen Li; Guang Peng; Xu Gao; Ke-Qin Dong; Hong-Ru Wang; De-Pei Kong; Min Qu; Li-He Dai; Kai-Jian Wang; Zhe Zhou; Jun Yang; Ze-Yu Yang; Yan-Qiong Cheng; Qin-Qin Tian; Dan Liu; Chuan-Liang Xu; Dan-Feng Xu; Xin-Gang Cui; Ying-Hao Sun
Journal:  Clin Cancer Res       Date:  2018-04-24       Impact factor: 12.531

Review 10.  Molecular regulation of bone marrow metastasis in prostate and breast cancer.

Authors:  Fakher Rahim; Saeideh Hajizamani; Esmaeil Mortaz; Ahmad Ahmadzadeh; Mohammad Shahjahani; Saeid Shahrabi; Najmaldin Saki
Journal:  Bone Marrow Res       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.